Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japan Researchers Develop Drug Delivery Superior To Chemo

This article was originally published in PharmAsia News

Executive Summary

Researchers in Japan say they have developed a substitute for chemotherapy, one capable of delivering drugs to targeted cancers. The development is seen as an advantage for treating cancers such as breast and ovarian, which have fewer blood vessels used by chemotherapy to do its work. The researchers found that tumor blood vessels differ from normal ones, featuring tiny gaps that could be exploited to deliver a drug. The result could lead to lower amounts of a drug doing the same job more effectively, and with fewer side effects. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts